- Home
- ITRM vs PRME Comparison
ITRM vs PRME Comparison
Compare ITRM & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- PRME
- Stock Information
- Founded
- ITRM 2015
- PRME 2019
- Country
- ITRM Ireland
- PRME United States
- Employees
- ITRM N/A
- PRME N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- PRME Medicinal Chemicals and Botanical Products
- Sector
- ITRM Health Care
- PRME Health Care
- Exchange
- ITRM Nasdaq
- PRME Nasdaq
- Market Cap
- ITRM 40.0M
- PRME 693.5M
- IPO Year
- ITRM 2018
- PRME 2022
- Fundamental
- Price
- ITRM $0.68
- PRME $5.12
- Analyst Decision
- ITRM Strong Buy
- PRME Buy
- Analyst Count
- ITRM 1
- PRME 6
- Target Price
- ITRM $9.00
- PRME $8.88
- AVG Volume (30 Days)
- ITRM 625.3K
- PRME 2.9M
- Earning Date
- ITRM 11-13-2025
- PRME 11-11-2025
- Dividend Yield
- ITRM N/A
- PRME N/A
- EPS Growth
- ITRM N/A
- PRME N/A
- EPS
- ITRM N/A
- PRME N/A
- Revenue
- ITRM N/A
- PRME $4,961,000.00
- Revenue This Year
- ITRM N/A
- PRME $179.58
- Revenue Next Year
- ITRM $482.25
- PRME N/A
- P/E Ratio
- ITRM N/A
- PRME N/A
- Revenue Growth
- ITRM N/A
- PRME 739.42
- 52 Week Low
- ITRM $0.61
- PRME $1.11
- 52 Week High
- ITRM $3.02
- PRME $5.17
- Technical
- Relative Strength Index (RSI)
- ITRM 43.37
- PRME 72.49
- Support Level
- ITRM $0.64
- PRME $3.09
- Resistance Level
- ITRM $0.70
- PRME $4.18
- Average True Range (ATR)
- ITRM 0.05
- PRME 0.35
- MACD
- ITRM 0.01
- PRME 0.15
- Stochastic Oscillator
- ITRM 47.57
- PRME 97.60
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.